202 related articles for article (PubMed ID: 35237178)
1. Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Extracellular Vesicles Promotes Hepatic Stellate Cell Activation, Liver Fibrosis and β-Catenin Signaling Pathway.
Wang T; Zhang C; Meng X; Zhu B; Wang S; Yuan W; Zhang S; Xu J; Zhang C
Front Physiol; 2022; 13():792182. PubMed ID: 35237178
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of serum extracellular vesicles in liver fibrosis.
Chen L; Chen R; Kemper S; Cong M; You H; Brigstock DR
J Extracell Vesicles; 2018; 7(1):1461505. PubMed ID: 29696080
[TBL] [Abstract][Full Text] [Related]
3. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
4. Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype.
Chiabotto G; Ceccotti E; Tapparo M; Camussi G; Bruno S
Front Cell Dev Biol; 2021; 9():777462. PubMed ID: 34796180
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
[TBL] [Abstract][Full Text] [Related]
7. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
8. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.
Povero D; Pinatel EM; Leszczynska A; Goyal NP; Nishio T; Kim J; Kneiber D; de Araujo Horcel L; Eguchi A; Ordonez PM; Kisseleva T; Feldstein AE
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184999
[TBL] [Abstract][Full Text] [Related]
9. Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway.
Hu J; Liu Y; Pan Z; Huang X; Wang J; Cao W; Chen Z
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983006
[TBL] [Abstract][Full Text] [Related]
10. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells.
Shi Z; Zhang K; Chen T; Zhang Y; Du X; Zhao Y; Shao S; Zheng L; Han T; Hong W
Cell Death Dis; 2020 Dec; 11(12):1066. PubMed ID: 33311456
[TBL] [Abstract][Full Text] [Related]
12. Human Liver Stem Cell Derived Extracellular Vesicles Alleviate Kidney Fibrosis by Interfering with the β-Catenin Pathway through miR29b.
Kholia S; Herrera Sanchez MB; Deregibus MC; Sassoè-Pognetto M; Camussi G; Brizzi MF
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639119
[TBL] [Abstract][Full Text] [Related]
13. MALAT1 promotes liver fibrosis by sponging miR‑181a and activating TLR4‑NF‑κB signaling.
Wang Y; Mou Q; Zhu Z; Zhao L; Zhu L
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34651657
[TBL] [Abstract][Full Text] [Related]
14. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
Yu F; Fan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
[TBL] [Abstract][Full Text] [Related]
15. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
[TBL] [Abstract][Full Text] [Related]
16. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
17. MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.
Yu F; Lu Z; Cai J; Huang K; Chen B; Li G; Dong P; Zheng J
Cell Cycle; 2015; 14(24):3885-96. PubMed ID: 26697839
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG11 reprograms glutaminolysis in hepatic stellate cells via Wnt/β-catenin/GLS axis.
Ying K; Zeng Y; Xu J; Wu X; Ying H; Cai W; Zhou R; Xu Q; Zhang X; Yu F
Biochem Pharmacol; 2024 Mar; 221():116044. PubMed ID: 38336157
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice.
Gong Q; Zeng Z; Jiang T; Bai X; Pu C; Hao Y; Guo Y
Front Nutr; 2022; 9():1009139. PubMed ID: 36276815
[TBL] [Abstract][Full Text] [Related]
20. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]